Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded site revision note: Revision v3.4.2. Removed older notices (Revision v3.4.1) and the funding-status message; no trial data or core page content was altered.SummaryDifference0.4%

- Check21 days agoChange DetectedThe study status was updated to Completed with revised completion and enrollment details, and a government funding/operating-status notice was added.SummaryDifference0.8%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated QC metadata to 'Last Update Submitted that Met QC Criteria' with revision 'v3.4.0'; removed the older QC label variants and the 'Revision: v3.3.4' label.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision update from v3.3.3 to v3.3.4. No substantive changes to study details or page content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows a consolidated Locations section for California, Michigan, and Missouri, replacing the separate California Locations, Michigan Locations, and Missouri Locations subsections; the revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check92 days agoChange DetectedTwo minor textual edits clarify PubMed-generated publications and update the page revision from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.